FDA approves new drug to reverse opioid overdose

United States News News

FDA approves new drug to reverse opioid overdose
United States Latest News,United States Headlines
  • 📰 wrtv
  • ⏱ Reading Time:
  • 22 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 51%

A new nasal spray can reverse the effects of an opioid overdose. The Food and Drug Administration gave its stamp of approval to Opvee, which can be used on patients 12 years and old...

The Food and Drug Administration gave its stamp of approval to Opvee, which can be used on patients 12 years and older.

"Opvee's FDA approval represents a significant achievement in the development of new treatment options to address today's era of opioid overdoses that are driven by powerful synthetic opioids, such as fentanyl," said Mark Crossley, CEO of Indivior, the pharmaceutical company that created Opvee. According to the Centers for Disease Control, more than 100,000 people in the U.S. died from an overdose in 2021.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

wrtv /  🏆 598. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Balsz Bistro: School district food truck ensuring students have access to healthy foodBalsz Bistro: School district food truck ensuring students have access to healthy foodDr. Barnes is talking about his district's new food truck, which has been in operation for the past year. It's a way to ensure students have better access to healthy food. MORE ⬇️
Read more »

Food pantries, Utah Food Bank see increase in demand heading into summer monthsFood pantries, Utah Food Bank see increase in demand heading into summer monthsThe Utah Food Bank and food pantries are seeing an increase in demand as schools let out and we head into the summer months and they're asking for more donations to help those in need. ChrisArnoldTV
Read more »

FDA Approves Autoinjector Pen for Humira Biosimilar, CyltezoFDA Approves Autoinjector Pen for Humira Biosimilar, CyltezoThe FDA approved a new autoinjection option for adalimumab-adbm, a biosimilar to AbbVie's adalimumab, ahead of Cyltezo's commercial launch on July 1, 2023.
Read more »

FDA Approves First Pill to Treat Moderate-to-Severe Crohn's DiseaseFDA Approves First Pill to Treat Moderate-to-Severe Crohn's DiseaseRinvoq is meant to treat adults with moderately to severely active Crohn's disease who have not had success with TNF (tumor necrosis factor) blockers. The daily pill is the first oral treatment for this group of patients.
Read more »

Veozah, new menopause drug for hot flashes, wins FDA approvalVeozah, new menopause drug for hot flashes, wins FDA approval“It’s going to be completely game changing for a lot of women,” one endocrinologist said.
Read more »



Render Time: 2025-02-23 07:33:56